Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Paola Fioretto's publication output changed over time?
ScholarIQpublication output · 1996–2016
Output grew200% over the shown period — from 1 works in 1996 to 3 in 2016.
1
1
2
1
1
1
1
1
3
199619982000200320052007200820132016
What are the most-cited papers on Paola Fioretto?
ScholarIQmost cited works
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Paola Fioretto, Michael W. Steffes, David E.R. Sutherland, Frederick C. Goetz, Michael Mauer
New England Journal of Medicine. 19981,137 Citations
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
Francesco Rubino, David M. Nathan, Robert H. Eckel, Philip R. Schauer, K. G. M. M. Alberti, Paul Zimmet, Stefano Del Prato, Linong Ji, S.M. Sadikot, William H. Herman, Stephanie A. Amiel, Lee M. Kaplan, Gaspar Taroncher‐Oldenburg, David E. Cummings, Delegates of the 2nd Diabetes Surgery Summit, Nizar Albache, Rachel L. Batterham, Deepak L. Bhatt, Camilo Boza, William T. Cefalu, Ricardo V. Cohen, Anita P. Courcoulas, Seán F. Dinneen, John B. Dixon, Ele Ferrannini, Paola Fioretto, Gema Frühbeck, Michel Gagner, Richard W. Grant, Sayeed Ikramuddin, Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Körner, Blandine Laferrère, Harold E. Lebovitz, Wei‐Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josép Vidal, Jianping Weng, Bruce M. Wolfe
Diabetes Care. 2016973 Citations
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
Donald E. Kohan, Paola Fioretto, Weihua Tang, James F. List
Kidney International. 2013647 CitationsOPEN ACCESS
Histopathology of Diabetic Nephropathy
Paola Fioretto, Michael Mauer
Seminars in Nephrology. 2007472 CitationsOPEN ACCESS
The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia
Jean‐Charles Fruchart, Frank M. Sacks, Michel P. Hermans, Gerd Assmann, W. Virgil Brown, R Češka, M. John Chapman, P M Dodson, Paola Fioretto, Henry N. Ginsberg, Takashi Kadowaki, Jean‐Marc Lablanche, Nikolaus Marx, Jorge Plutzky, Željko Reiner, Robert S. Rosenson, Bart Staels, Jane K. Stock, Rody G. Sy, Christoph Wanner, Alberto Zambon, Paul Zimmet
The American Journal of Cardiology. 2008462 Citations
Related on ScholarIQ
University of Padua
Institution
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Paper
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
Paper
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
Paper
Histopathology of Diabetic Nephropathy
Paper
The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia
Paper